EyePoint Pharmaceuticals, Inc. - EYPT

SEC FilingsOur EYPT Tweets

About Gravity Analytica

Recent News

  • 09.16.2025 - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 09.16.2025 - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 09.16.2025 - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 09.03.2025 - Cantor Global Healthcare Conference
  • 09.03.2025 - Cantor Global Healthcare Conference
  • 09.02.2025 - Citi’s 2025 BioPharma Back to School Conference
  • 09.02.2025 - Citi’s 2025 BioPharma Back to School Conference
  • 08.26.2025 - EyePoint Announces Participation at Upcoming Investor Conferences
  • 08.26.2025 - EyePoint Announces Participation at Upcoming Investor Conferences
  • 08.26.2025 - EyePoint Announces Participation at Upcoming Investor Conferences

Recent Filings

  • 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.07.2025 - S-8 Securities to be offered to employees in employee benefit plans